Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| nivolumab | Nivolumab, marketed as Opdivo, is a humanized IgG4 anti-PD-1 monoclonal antibody used to treat cancer. Nivolumab works as a checkpoint inhibitor, blocking a signal that would have prevented activated T cells from attacking the cancer, thus allowing the immune system to clear the cancer. Synonyms: Opdivo; ONO-4538; BMS-936558; MDX1106; ONO4538; BMS936558; MDX 1106; ONO 4538; BMS 936558; MDX-1106. CAS No. 946414-94-4. |  |
| Nivolumab | Nivolumab Inhibitor. Uses: Scientific use. Product Category: T9907. CAS No. 946414-94-4. |  |
| Nivolumab | Nivolumab is a programmed death receptor-1 ( PD-1 ) blocking human IgG4 antibody to treat advanced (metastatic) non-small cell lung cancer. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: BMS-936558; ONO-4538; MDX-1106. CAS No. 946414-94-4. Pack Sizes: 1 mg; 5 mg. Product ID: HY-P9903. |  |
| BMS-986205 | BMS-986205 is a selective indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor. It is undergoing a phase I/II clinical trial for the bladder and cervical cancer therapy in combination with nivolumab, an anti-programmed cell death protein 1 (PD-1) monoclonal antibody. Uses: Drug combination with nivolumab. Synonyms: BMS-986205; BMS 986205; BMS986205; (2R)-N-(4-chlorophenyl)-2-[4-(6-fluoroquinolin-4-yl)cyclohexyl]propanamide. CAS No. 1923833-60-6. Molecular formula: C24H24ClFN2O. Mole weight: 410.917. | |
| Cabiralizumab | Cabiralizumab (FPA 008) is an anti- CSF1R monoclonal antibody (MAb). Cabiralizumab enhances T cell infiltration and antitumor T cell immune responses. Cabiralizumab inhibits the activation of osteoclasts and blocks bone destruction, and can be used in the research of rheumatoid arthritis (RA). Cabiralizumab can combine with Nivolumab (HY-P9903) for lung cancer research [1] [2]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: FPA 008; Anti-Human CSF1R Recombinant Antibody. CAS No. 1613144-80-1. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99259. | |
| Visugromab | Visugromab (CTL-002) is a GDF-15 neutralizing IgG4 mAb. Visugromab has synergistic anticancer activity with the anti-PD1 antibody Nivolumab (HY-P9903) and can effectively act on PD-1/PD-L1 relapsed/refractory metastatic solid tumors [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: CTL-002. CAS No. 2556646-63-8. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99100. | |
Our database is helping our users find suppliers everyday.
